TipRanks
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market
CAMP
CAMP4 Therapeutics Corporation
RESEARCH TOOLSreports
Want to see CAMP full AI Analyst Report?

CAMP4 Therapeutics Corporation (CAMP) Income Statement

136 Followers

CAMP4 Therapeutics Corporation Income Statement

Last quarter (Q2 2026), CAMP4 Therapeutics Corporation's total revenue was $1.78M, an increase of 18.84% from the same quarter last year. In Q2, CAMP4 Therapeutics Corporation's net income was $-33.53M. See CAMP4 Therapeutics Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Nov 23Feb 23Feb 22
Total Revenue
$ 3.50M$ 652.00K$ 350.00K$ 294.95M$ 295.84M
Gross Profit
$ 1.86M$ 652.00K$ 350.00K$ 109.01M$ 121.89M
Operating Expenses
$ 53.92M$ 53.74M$ 52.23M$ 133.70M$ 134.76M
Depreciation and Amortization
$ 1.64M$ 1.70M$ 1.68M$ 0.00$ 22.80M
EBITDA
$ -50.42M$ -51.39M$ -50.20M$ -25.08M$ -2.64M
Operating Income
$ -52.06M$ -53.09M$ -51.88M$ -24.68M$ -13.47M
Other Income/Expenses
$ -28.34M$ 1.30M$ 2.59M$ -6.65M$ -1.87M
Pretax Income
$ -80.40M$ -51.79M$ -49.29M$ -31.34M$ -30.06M
Net Income
$ -80.40M$ -51.79M$ -49.29M$ -32.49M$ -27.99M
Per Share Metrics
Basic EPS
$ -2.65$ -2.66$ -4.07$ -0.90$ 0.00
Diluted EPS
$ -2.65$ -2.66$ -4.07$ -0.90$ 0.00
Weighted Average Shares Outstanding
 30.38M 19.51M 12.12M 36.13M 1.53M
Weighted Average Shares Outstanding (Diluted)
 30.38M 19.51M 12.12M 36.13M 1.53M
Currency in USD

CAMP4 Therapeutics Corporation Earnings and Revenue History